Scandinavian Journal of Rheumatology, Volume 51, Issue 3 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Scandinavian Journal of Rheumatology, Volume 51, Issue 3 (2022)

See all volumes and issues
Vol 53, 2024 Vol 52, 2023 Volume 51, 2022 Vol 50, 2021 Vol 49, 2020 Vol 48, 2019 Vol 47, 2018 Vol 46, 2017 Vol 45, 2016 Vol 44, 2015 Vol 43, 2014 Vol 42, 2013 Vol 41, 2012 Vol 40, 2011 Vol 39, 2010 Vol 38, 2009 Vol 37, 2008 Vol 36, 2007 Vol 35, 2006 Vol 34, 2005 Vol 33, 2004 Vol 32, 2003 Vol 31, 2002 Vol 30, 2001 Vol 29, 2000 Vol 28, 1999 Vol 27, 1998 Vol 26, 1997 Vol 25, 1996 Vol 24, 1995 Vol 23, 1994 Vol 22, 1993 Vol 21, 1992 Vol 20, 1991 Vol 19, 1990-1991 Vol 18, 1988-1989 Vol 17, 1988 Vol 16, 1987 Vol 15, 1986 Vol 14, 1985 Vol 13, 1984 Vol 12, 1983 Vol 11, 1982 Vol 10, 1981 Vol 9, 1980 Vol 8, 1979 Vol 7, 1978 Vol 6, 1977 Vol 5, 1976 Vol 4, 1975-1976 Vol 3, 1974 Vol 2, 1973 Vol 1, 1972 Vol 17, 1971 Vol 16, 1970-1971 Vol 15, 1969-1970 Vol 14, 1968-1969 Vol 13, 1967-1968 Vol 12, 1966-1967 Vol 11, 1965 Vol 10, 1964-1965 Vol 9, 1963 Vol 8, 1962 Vol 7, 1961 Vol 6, 1960 Vol 5, 1959 Vol 4, 1958 Vol 3, 1957 Vol 2, 1956 Vol 1, 1955
Download citations Download PDFs Download issue

Articles/Brief Reports

Article
No difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort
JK Pedersen, K Andersen, AJ Svendsen & K Hørslev-Petersen
Pages: 173-179
Published online: 29 Jun 2021
AbstractforNo difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort | Full Text | References | PDF (133 KB) | EPUB
  • 118 Views
  • 3 CrossRef citations
  • 0Altmetric
Brief Report
Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab
K Vuolteenaho, L Tuure, R Nieminen, L Laasonen, M Leirisalo-Repo, E Moilanen & NEO-RACo Study Group
Pages: 180-185
Published online: 15 Jul 2021
AbstractforPretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab | Full Text | References | PDF (630.3 KB) | EPUB | Supplemental
  • 1692 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Article
Degree of arterial stiffness is comparable across inflammatory joint disease entities
FK Föhse, S Rollefstad, E Ikdahl, G Wibetoe, J Sexton, J Hisdal & AG Semb
Pages: 186-195
Published online: 16 Jun 2021
AbstractforDegree of arterial stiffness is comparable across inflammatory joint disease entities | Full Text | References | PDF (283.6 KB) | EPUB
  • 1244 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Ultrasound Doppler enthesitis shows sensitivity to change after biological therapy in spondyloarthritis and psoriatic arthritis patients
J Molina Collada, C Macía-Villa, C Plasencia-Rodríguez, JM Álvaro-Gracia & E de Miguel
Pages: 196-204
Published online: 21 Jun 2021
AbstractforUltrasound Doppler enthesitis shows sensitivity to change after biological therapy in spondyloarthritis and psoriatic arthritis patients | Full Text | References | PDF (6 MB) | EPUB
  • 304 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis
M Clerte, R Philip, C Levi, E Cornec-Le Gall, V Audard, A Huart, X Puéchal, M Touzot, N Rabot, É Thervet, A Aouba & A Karras
Pages: 205-213
Published online: 25 Jun 2021
AbstractforRenal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis | Full Text | References | PDF (254.6 KB) | EPUB
  • 311 Views
  • 3 CrossRef citations
  • 0Altmetric
Brief Report
Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study
L Johansson, E Berglin, O Eriksson, AJ Mohammad, J Dahlqvist & S Rantapää-Dahlqvist
Pages: 214-219
Published online: 20 Jan 2022
AbstractforComplement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study | Full Text | References | PDF (324.9 KB) | EPUB
  • 1687 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Increased salivary syndecan-1 level is associated with salivary gland function and inflammation in patients with Sjögren’s syndrome
NY Lee, NR Kim, JW Kang, G Kim, M-S Han, JA Jang, D Ahn, JH Jeong, M-H Han & EJ Nam
Pages: 220-229
Published online: 02 Jul 2021
AbstractforIncreased salivary syndecan-1 level is associated with salivary gland function and inflammation in patients with Sjögren’s syndrome | Full Text | References | PDF (3.2 MB) | EPUB | Supplemental
  • 188 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study
D Gorczyca, B Szponar, M Paściak, A Czajkowska & M Szmyrka
Pages: 230-236
Published online: 25 Jun 2021
AbstractforSerum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study | Full Text | References | PDF (160.1 KB) | EPUB
  • 1624 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Brief Report
Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy
R Biesen, M Frese-Schaper, P Enghard, Q Cheng, F Hiepe & S Frese
Pages: 237-240
Published online: 02 Nov 2021
AbstractforRefractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy | Full Text | References | PDF (1.1 MB) | EPUB
  • 1315 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Letters

The Risk of overdiagnosis and overtreatment in spondyloarthritis
A Ortolan, M Lorenzin, A Doria & R Ramonda
Pages: 241-242
Published online: 20 Jan 2022
CitationforThe Risk of overdiagnosis and overtreatment in spondyloarthritis | Full Text | References | PDF (538.9 KB) | EPUB
  • 134 Views
  • 2 CrossRef citations
  • 0Altmetric
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy
C Campochiaro, A Tomelleri, N Farina, G Cavalli, G De Luca, A Palmisano, G Peretto, A Esposito, S Rizzo, C Basso, M Matucci-Cerinic & L Dagna
Pages: 243-245
Published online: 17 Nov 2021
First Page PreviewforMyocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy | Full Text | References | PDF (1.2 MB) | EPUB
  • 120 Views
  • 3 CrossRef citations
  • 0Altmetric
Reduced glomerular filtrate rate, end-stage renal disease, scleroderma renal crisis, and risk of mortality in patients with systemic sclerosis
A Gigante & E Rosato
Pages: 246-247
Published online: 17 Nov 2021
CitationforReduced glomerular filtrate rate, end-stage renal disease, scleroderma renal crisis, and risk of mortality in patients with systemic sclerosis | Full Text | References | PDF (66.3 KB) | EPUB
  • 128 Views
  • 0 CrossRef citations
  • 0Altmetric
Systemic autoimmunity with Castleman-like lymphadenopathy: a diagnostic and therapeutic challenge
C Wang
Pages: 248-249
Published online: 11 Jan 2022
CitationforSystemic autoimmunity with Castleman-like lymphadenopathy: a diagnostic and therapeutic challenge | Full Text | References | PDF (82.5 KB) | EPUB
  • 84 Views
  • 0 CrossRef citations
  • 0Altmetric
Comment on ‘Systemic autoimmunity with Castleman-like lymphadenopathy: a diagnostic and therapeutic challenge’: reply
M Saleh & C Sjöwall
Pages: 250-251
Published online: 17 Nov 2021
CitationforComment on ‘Systemic autoimmunity with Castleman-like lymphadenopathy: a diagnostic and therapeutic challenge’: reply | Full Text | References | PDF (78.6 KB) | EPUB
  • 70 Views
  • 1 CrossRef citations
  • 0Altmetric
A temporal cluster of cutaneous drug eruptions developing after initiation of hydroxychloroquine
S Jadeja, LA Temiz, AK Dewan & ER Parker
Pages: 252-254
Published online: 10 Feb 2022
First Page PreviewforA temporal cluster of cutaneous drug eruptions developing after initiation of hydroxychloroquine | Full Text | References | PDF (2.8 MB) | EPUB
  • 113 Views
  • 1 CrossRef citations
  • 0Altmetric
Case Report
Anti-synthetase syndrome occurring after SARS-CoV-2 infection
M Bouchard Marmen, B Ellezam, MJ Fritzler, Y Troyanov, PV Gould, M Satoh, A Meyer, Z Mahjoub & O Landon-Cardinal
Pages: 255-257
Published online: 09 Feb 2022
First Page PreviewforAnti-synthetase syndrome occurring after SARS-CoV-2 infection | Full Text | References | PDF (3.2 MB) | EPUB
  • 175 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles